SABCS 2010: Interview with Robert E. Coleman, M.D., professor of medical oncology, University of Sheffield, UK
Dr. Coleman, chief investigator of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial, presents the rationale for studying the bisphosphonate zoledronic acid, and the final results of this study.
Download* the m4v of the video (62.9 MB, 5:35 minutes)
*On a PC, right mouse click on the “Download” link and select “Save link as…” in Firefox or “Save Target as…” in Internet Explorer.
Updated: December 3, 2010